Clinical Outcomes of MICROPURE and PodEye Monofocal Intraocular Lenses

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

June 17, 2021

Study Completion Date

June 17, 2021

Conditions
CataractLens Opacities
Interventions
DEVICE

Micropure 1.2.3.

"Implantation of intraocular lens (IOL). Name: MicroPure 1.2.3. It is a monofocal intraocular lens consisting of hydrophobic acrylic material. One IOL per patient will be implanted"

DEVICE

PODEYE

"Implantation of intraocular lens (IOL). Name: PODEYE It is a monofocal intraocular lens consisting of hydrophobic acrylic material. The IOL will be implanted in the contralateral eye of the same patient already implanted with Micropure 1.2.3."

Trial Locations (1)

76001

GEMINI Eye Clinic, Zlín

All Listed Sponsors
lead

Beaver-Visitec International, Inc.

INDUSTRY

NCT03796624 - Clinical Outcomes of MICROPURE and PodEye Monofocal Intraocular Lenses | Biotech Hunter | Biotech Hunter